{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:09:36Z","timestamp":1789013376729,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The aim of this study was to investigate the association of microRNA-345-3p (miR-345-3p) with liver metastasis in colorectal cancer (CRC) and to explore its underlying molecular mechanisms using in vitro approaches.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Serum specimens were collected from 110 CRC patients and 90 healthy individuals. Quantitative real-time PCR (qRT-PCR) was employed to assess the expression levels of miR-345-3p and KH RNA binding domain containing, signal transduction associated 1 (KHDRBS1) expression. The associations of miR-345-3p with clinical pathological characteristics, survival, and liver metastasis were analyzed. In vitro cell experiments were conducted to validate the effects of miR-345-3p on CRC cell growth and epithelial-mesenchymal transition (EMT). Target genes and signaling pathways were verified using luciferase reporter assays, rescue experiments, and Western blot analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A significant decrease in miR-345-3p expression was observed in CRC patients with liver metastasis. Low levels of miR-345-3p were correlated with advanced tumor node metastasis (TNM) stages, deeper invasion, lymph node metastasis, and poorer prognosis. Overexpression of miR-345-3p inhibited CRC cell growth and suppressed EMT-associated molecular changes. Bioinformatics analyses and experimental results confirmed KHDRBS1 as a direct target gene of miR-345-3p. Furthermore, rescue experiments demonstrated that overexpression of KHDRBS1 reverses the tumor-suppressive effects of miR-345-3p, indicating that miR-345-3p functions by regulating the transforming growth factor-\u03b2 (TGF-\u03b2) signaling pathway.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Decreased circulating levels of miR-345-3p are associated with liver metastasis in CRC. In vitro studies suggest that miR-345-3p may exert its tumor-suppressive effects by targeting KHDRBS1 and suppressing the TGF-\u03b2 signaling pathway, thereby inhibiting CRC cell migration and invasive capacity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41065-026-00715-5","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T07:53:29Z","timestamp":1785398009000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MicroRNA-345-3p expression inhibits colorectal cancer liver metastasis by targeting KHDRBS1 and TGF-\u03b2 signaling pathway"],"prefix":"10.1186","volume":"163","author":[{"given":"Song","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songjie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangting","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"issue":"9","key":"715_CR1","doi-asserted-by":"publisher","first-page":"998","DOI":"10.2174\/18735592MTEx9NTk2y","volume":"22","author":"F Baidoun","year":"2021","unstructured":"Baidoun F, Elshiwy K, Elkeraie Y, Merjaneh Z, Khoudari G, Sarmini MT, et al. Colorectal Cancer Epidemiology: Recent Trends and Impact on Outcomes. Curr Drug Targets. 2021;22(9):998\u20131009.","journal-title":"Curr Drug Targets"},{"issue":"33","key":"715_CR2","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.3748\/wjg.v30.i33.3818","volume":"30","author":"SC Liu","year":"2024","unstructured":"Liu SC, Zhang H. Early diagnostic strategies for colorectal cancer. World J Gastroenterol. 2024;30(33):3818\u201322.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"715_CR3","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41392-024-01953-7","volume":"9","author":"Q Li","year":"2024","unstructured":"Li Q, Geng S, Luo H, Wang W, Mo YQ, Luo Q, et al. Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy. Signal Transduct Target Ther. 2024;9(1):266.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"715_CR4","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1186\/s12967-025-06863-y","volume":"23","author":"G Peng","year":"2025","unstructured":"Peng G, Zhong L, Luo L, Ju Y, Lu Y, Ng L, et al. Cancer cell SPOCD1 promotes colorectal cancer liver metastasis by activating the CXCL12\/CXCR4 signaling pathway in cancer-associated fibroblasts. J Transl Med. 2025;23(1):902.","journal-title":"J Transl Med"},{"issue":"5","key":"715_CR5","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s12026-024-09478-5","volume":"72","author":"IH Song","year":"2024","unstructured":"Song IH, Lee SB, Jeong BK, Park J, Kim H, Lee G, et al. T cell receptor clonotype in tumor microenvironment contributes to intratumoral signaling network in patients with colorectal cancer. Immunol Res. 2024;72(5):921\u201337.","journal-title":"Immunol Res"},{"key":"715_CR6","doi-asserted-by":"crossref","unstructured":"Ionescu VA, Gheorghe G, Bacalbasa N, Chiotoroiu AL, Diaconu C. Colorectal Cancer: From Risk Factors to Oncogenesis. Med (Kaunas). 2023;59(9):1646.","DOI":"10.3390\/medicina59091646"},{"issue":"3","key":"715_CR7","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S2468-1253(21)00426-X","volume":"7","author":"SG Patel","year":"2022","unstructured":"Patel SG, Karlitz JJ, Yen T, Lieu CH, Boland CR. The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection. Lancet Gastroenterol Hepatol. 2022;7(3):262\u201374.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"8","key":"715_CR8","doi-asserted-by":"publisher","first-page":"e358","DOI":"10.1016\/S1470-2045(21)00343-0","volume":"22","author":"N Zhang","year":"2021","unstructured":"Zhang N, Ng AS, Cai S, Li Q, Yang L, Kerr D. Novel therapeutic strategies: targeting epithelial-mesenchymal transition in colorectal cancer. Lancet Oncol. 2021;22(8):e358\u201368.","journal-title":"Lancet Oncol"},{"key":"715_CR9","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1017\/erm.2021.13","volume":"23","author":"L Han","year":"2021","unstructured":"Han L, Wang S, Wei C, Fang Y, Huang S, Yin T, et al. Tumour microenvironment: a non-negligible driver for epithelial-mesenchymal transition in colorectal cancer. Expert Rev Mol Med. 2021;23:e16.","journal-title":"Expert Rev Mol Med"},{"key":"715_CR10","doi-asserted-by":"publisher","first-page":"153303382210812","DOI":"10.1177\/15330338221081219","volume":"21","author":"Q Ni","year":"2022","unstructured":"Ni Q, Li M, Yu S. Research Progress of Epithelial-mesenchymal Transition Treatment and Drug Resistance in Colorectal Cancer. Technol Cancer Res Treat. 2022;21:15330338221081219.","journal-title":"Technol Cancer Res Treat"},{"issue":"4","key":"715_CR11","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.tips.2023.01.003","volume":"44","author":"AE Shin","year":"2023","unstructured":"Shin AE, Giancotti FG, Rustgi AK. Metastatic colorectal cancer: mechanisms and emerging therapeutics. Trends Pharmacol Sci. 2023;44(4):222\u201336.","journal-title":"Trends Pharmacol Sci"},{"issue":"8","key":"715_CR12","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1158\/0008-5472.CAN-23-2123","volume":"84","author":"X Liu","year":"2024","unstructured":"Liu X, Wang X, Yang Q, Luo L, Liu Z, Ren X, et al. Th17 Cells Secrete TWEAK to Trigger Epithelial-Mesenchymal Transition and Promote Colorectal Cancer Liver Metastasis. Cancer Res. 2024;84(8):1352\u201371.","journal-title":"Cancer Res"},{"key":"715_CR13","doi-asserted-by":"publisher","first-page":"e150923221164","DOI":"10.2174\/1874467217666230915125622","volume":"17","author":"Y Ruan","year":"2024","unstructured":"Ruan Y, Lu G, Yu Y, Luo Y, Wu H, Shen Y, et al. PF-04449913 Inhibits Proliferation and Metastasis of Colorectal Cancer Cells by Down-regulating MMP9 Expression through the ERK\/p65 Pathway. Curr Mol Pharmacol. 2024;17:e150923221164.","journal-title":"Curr Mol Pharmacol"},{"issue":"6","key":"715_CR14","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2174\/0109298665297110240611115010","volume":"31","author":"H Ge","year":"2024","unstructured":"Ge H, Yan Y, Wang H, Bian J, Deng Z, Su X, et al. Circular RNA hsa_circ_0005939 Regulates UHRF1BP1L Expression by Targeting miR-4693-3p to Promote Colorectal Cancer Progression. Protein Pept Lett. 2024;31(6):437\u201346.","journal-title":"Protein Pept Lett"},{"issue":"2","key":"715_CR15","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2174\/0109298665256238231120093150","volume":"31","author":"M Wu","year":"2024","unstructured":"Wu M, Wu X, Han J. KIF20A Promotes CRC Progression and the Warburg Effect through the C-Myc\/HIF-1alpha Axis. Protein Pept Lett. 2024;31(2):107\u201315.","journal-title":"Protein Pept Lett"},{"issue":"7","key":"715_CR16","doi-asserted-by":"publisher","first-page":"544","DOI":"10.2174\/0109298665305114240718072029","volume":"31","author":"S Tian","year":"2024","unstructured":"Tian S, Chen M, Jing W, Meng Q, Wu J. miR-1204 Positioning in 8q24.21 Involved in the Tumorigenesis of Colorectal Cancer by Targeting MASPIN. Protein Pept Lett. 2024;31(7):544\u201358.","journal-title":"Protein Pept Lett"},{"issue":"1","key":"715_CR17","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s12029-025-01314-9","volume":"56","author":"H Shah","year":"2025","unstructured":"Shah H, Khan NA, Ullah MI, Khan UZ, Irfan U, Ahmad I. Comparative Efficacy of Thermal Ablation and Surgical Resection in Patients with Colorectal Cancer Liver Metastasis: A Systematic Review and Meta-analysis. J Gastrointest Cancer. 2025;56(1):188.","journal-title":"J Gastrointest Cancer"},{"key":"715_CR18","doi-asserted-by":"publisher","first-page":"111528","DOI":"10.1016\/j.biopha.2021.111528","volume":"138","author":"BM Hussen","year":"2021","unstructured":"Hussen BM, Hidayat HJ, Salihi A, Sabir DK, Taheri M, Ghafouri-Fard S. MicroRNA: A signature for cancer progression. Biomed Pharmacother. 2021;138:111528.","journal-title":"Biomed Pharmacother"},{"key":"715_CR19","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.canlet.2020.12.025","volume":"501","author":"X Huang","year":"2021","unstructured":"Huang X, Zhu X, Yu Y, Zhu W, Jin L, Zhang X, et al. Dissecting miRNA signature in colorectal cancer progression and metastasis. Cancer Lett. 2021;501:66\u201382.","journal-title":"Cancer Lett"},{"key":"715_CR20","doi-asserted-by":"publisher","first-page":"101540","DOI":"10.1016\/j.molmet.2022.101540","volume":"63","author":"K Xu","year":"2022","unstructured":"Xu K, Xia P, Gongye X, Zhang X, Ma S, Chen Z, et al. A novel lncRNA RP11-386G11.10 reprograms lipid metabolism to promote hepatocellular carcinoma progression. Mol Metab. 2022;63:101540.","journal-title":"Mol Metab"},{"issue":"2","key":"715_CR21","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1093\/carcin\/bgab124","volume":"43","author":"Q Zeng","year":"2022","unstructured":"Zeng Q, Jin F, Qian H, Chen H, Wang Y, Zhang D, et al. The miR-345-3p\/PPP2CA signaling axis promotes proliferation and invasion of breast cancer cells. Carcinogenesis. 2022;43(2):150\u20139.","journal-title":"Carcinogenesis"},{"issue":"1","key":"715_CR22","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12943-018-0860-7","volume":"17","author":"X Wang","year":"2018","unstructured":"Wang X, Yu H, Sun W, Kong J, Zhang L, Tang J, et al. The long non-coding RNA CYTOR drives colorectal cancer progression by interacting with NCL and Sam68. Mol Cancer. 2018;17(1):110.","journal-title":"Mol Cancer"},{"issue":"9","key":"715_CR23","doi-asserted-by":"publisher","first-page":"e24145","DOI":"10.1371\/journal.pone.0024145","volume":"6","author":"MB Kirschner","year":"2011","unstructured":"Kirschner MB, Kao SC, Edelman JJ, Armstrong NJ, Vallely MP, van Zandwijk N, et al. Haemolysis during sample preparation alters microRNA content of plasma. PLoS ONE. 2011;6(9):e24145.","journal-title":"PLoS ONE"},{"issue":"1","key":"715_CR24","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.ymeth.2012.09.015","volume":"59","author":"T Blondal","year":"2013","unstructured":"Blondal T, Jensby Nielsen S, Baker A, Andreasen D, Mouritzen P, Wrang Teilum M, et al. Assessing sample and miRNA profile quality in serum and plasma or other biofluids. Methods. 2013;59(1):S1\u20136.","journal-title":"Methods"},{"issue":"3","key":"715_CR25","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.arcmed.2022.01.004","volume":"53","author":"Y Li","year":"2022","unstructured":"Li Y, Lv Y, Wang J, Zhu X, Chen J, Zhang W, et al. LncRNA NORAD Mediates the Proliferation and Apoptosis of Diffuse Large-B-Cell Lymphoma via Regulation of miR-345-3p\/TRAF6 Axis. Arch Med Res. 2022;53(3):271\u20139.","journal-title":"Arch Med Res"},{"key":"715_CR26","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s12935-020-01416-3","volume":"20","author":"J Cao","year":"2020","unstructured":"Cao J, Tang Z, Su Z. Long non-coding RNA LINC01426 facilitates glioblastoma progression via sponging miR-345-3p and upregulation of VAMP8. Cancer Cell Int. 2020;20:327.","journal-title":"Cancer Cell Int"},{"key":"715_CR27","doi-asserted-by":"crossref","unstructured":"Scholtz B, Horvath J, Tar I, Kiss C, Marton IJ. Salivary miR-31-5p, miR-345-3p, and miR-424-3p Are Reliable Biomarkers in Patients with Oral Squamous Cell Carcinoma. Pathogens. 2022;11(2):229.","DOI":"10.3390\/pathogens11020229"},{"issue":"4","key":"715_CR28","first-page":"546","volume":"34","author":"L Wang","year":"2014","unstructured":"Wang L, Cui Y, Liao W, Liu S. [Role of Sam68 in proliferation, invasion and migration of colorectal cancer cells in vitro]. Nan Fang Yi Ke Da Xue Xue Bao. 2014;34(4):546\u201351.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"715_CR29","doi-asserted-by":"publisher","first-page":"1393801","DOI":"10.3389\/fimmu.2024.1393801","volume":"15","author":"R Fan","year":"2024","unstructured":"Fan R, Liu F, Gong Q, Liu D, Tang S, Shen D. KHDRBS1 as a novel prognostic signaling biomarker influencing hepatocellular carcinoma cell proliferation, migration, immune microenvironment, and drug sensitivity. Front Immunol. 2024;15:1393801.","journal-title":"Front Immunol"},{"key":"715_CR30","doi-asserted-by":"crossref","unstructured":"Lai XN, Li J, Tang LB, Chen WT, Zhang L, Xiong LX. MiRNAs and LncRNAs: Dual Roles in TGF-beta Signaling-Regulated Metastasis in Lung Cancer. Int J Mol Sci. 2020;21(4):1193.","DOI":"10.3390\/ijms21041193"},{"issue":"12","key":"715_CR31","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1038\/s41588-025-02380-2","volume":"57","author":"A Henriques","year":"2025","unstructured":"Henriques A, Salvany-Celades M, Nieto P, Palomo-Ponce S, Sevillano M, Hernando-Momblona X, et al. TGF-beta builds a dual immune barrier in colorectal cancer by impairing T cell recruitment and instructing immunosuppressive SPP1(+) macrophages. Nat Genet. 2025;57(12):3050\u201365.","journal-title":"Nat Genet"},{"key":"715_CR32","doi-asserted-by":"publisher","first-page":"155709","DOI":"10.1016\/j.cyto.2021.155709","volume":"148","author":"J Wang","year":"2021","unstructured":"Wang J, Xu Z, Wang Z, Du G, Lun L. TGF-beta signaling in cancer radiotherapy. Cytokine. 2021;148:155709.","journal-title":"Cytokine"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-026-00715-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-026-00715-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-026-00715-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:56:38Z","timestamp":1789012598000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41065-026-00715-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["715"],"URL":"https:\/\/doi.org\/10.1186\/s41065-026-00715-5","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"assertion":[{"value":"11 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Prior to participation, all subjects received a comprehensive explanation of the study protocol and voluntarily signed written informed consent forms. The Ethics Committee of Xinxiang Central Hospital approved this study. All methods were performed in accordance with relevant guidelines, regulations and the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"95"}}